Bill Cheliak Tetra Bio-Pharma
Tetra Bio-Pharma has appointed CEO of cannabinoid-focused Panag Pharma, Bill Cheliak, to its Board of Directors.
Cheliak joins the Canada-based firm as it invests in cannabis-based treatments.
“As Tetra is now completely focused on becoming a global leader in pharmaceutical cannabis, Dr. Cheliak’s strong pharmaceutical background, knowledge and extensive networks will support the Company in the execution of its business plan,” said Tetra Bio-Pharma CEO Andre Rancourt.
Cheliak has previously worked for a variety of pharmaceutical-focused companies, including for firms specialised in human genetics, oncology, vaccines, neurology and anti-infective drug development and CRO services.
